首頁 > 市場調查報告書 > 醫療設備

體外診斷生技設備

市場調查報告書

商品編碼

1866523

全球聚合酵素鏈鎖反應（PCR）市場－2025-2030年預測

Global Polymerase Chain Reaction (PCR) Market - Forecasts from 2025 to 2030

出版日期: 2025年11月05日 | 出版商:

Knowledge Sourcing Intelligence | 英文 140 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄

聚合酵素鏈鎖反應(PCR) 市場預計將從 2025 年的 115.21 億美元成長到 2030 年的 164.86 億美元，複合年成長率為 7.43%。

由於聚合酵素鏈鎖反應(PCR) 在臨床診斷、藥物研發以及研究開發中擴增特定 DNA 區域方面發揮關鍵作用，全球 PCR 市場預計將迎來顯著成長。 PCR 是一種體外技術，它利用耐熱 Taq聚合酵素、DNA 引子、核苷酸鹼基和緩衝液，透過熱感循環（變性、退火和延伸步驟）產生數百萬個 DNA 拷貝。過程重複 20 至 40 次，每次循環使 DNA 拷貝數翻倍，並以電泳進行檢驗。 PCR 廣泛應用於分子生物學、醫學診斷、法醫學分析和生態學，仍是基因分析和檢測的基礎技術。

市場促進因素

PCR技術在臨床診斷中的應用日益廣泛，尤其是在感染疾病和遺傳性疾病的檢測方面，是推動市場成長要素。其在生物標記鑑定和藥物研發（包括個人化醫療）中的作用也促進了市場需求。試劑特異性的提高和PCR系統自動化等技術進步提高了效率和準確性，從而推動了市場成長。慢性疾病（包括癌症和代謝性疾病）盛行率的上升也推動了對PCR等先進診斷工具的需求，進而促進了市場擴張。

市場限制

PCR設備及相關耗材的高成本構成了一項重大挑戰，尤其對於小規模的實驗室和發展中地區的實驗室而言更是如此。儘管該技術應用廣泛，但這一成本壁壘可能會限制其普及化並抑制市場成長。

介紹
北美洲
- 依產品類型
- 透過技術
- 透過使用
- 按國家/地區
  - 美國
  - 加拿大
  - 墨西哥
南美洲
- 依產品類型
- 透過技術
- 透過使用
- 按國家/地區
  - 巴西
  - 阿根廷
  - 其他
歐洲
- 依產品類型
- 透過技術
- 透過使用
- 按國家/地區
  - 英國
  - 德國
  - 法國
  - 義大利
  - 其他
中東和非洲
- 依產品類型
- 透過技術
- 透過使用
- 按國家/地區
  - 沙烏地阿拉伯
  - 阿拉伯聯合大公國
  - 其他
亞太地區
- 依產品類型
- 透過技術
- 透過使用
- 按國家/地區
  - 日本
  - 中國
  - 印度
  - 韓國
  - 台灣
  - 其他

第9章：競爭格局與分析

主要企業和策略分析
市佔率分析
企業合併、協議、商業合作
競爭對手儀錶板

第10章：公司簡介

Thermo Fisher Scientific Inc.
Abbott Laboratories
Agilent Technologies, Inc.
Siemens Healthineers AG
Becton, Dickinson and Company
Promega Corporation
bioMerieux SA
Merck KGaA
Bio-Rad Laboratories, Inc.
GE Healthcare
QIAGEN NV
F. Hoffmann-La Roche Ltd.
Danaher Corporation

第11章分析方法

簡介目錄

Product Code: KSI061611928

The Polymerase Chain Reaction (PCR) Market is set to grow from USD 11.521 billion in 2025 to USD 16.486 billion by 2030, registering a 7.43% CAGR.

The global polymerase chain reaction (PCR) market is poised for significant growth, driven by its critical role in amplifying specific DNA regions for applications in clinical diagnostics, drug development, and research. PCR, an in vitro technique utilizing thermostable Taq polymerase, DNA primers, nucleotide bases, and a buffer, enables the generation of millions of DNA copies through thermal cycling (denaturing, annealing, and extending stages). This process, repeated 20-40 times, doubles DNA copies per cycle and is validated using electrophoresis. Widely used in molecular biology, medical diagnostics, forensic analysis, and ecology, PCR remains a cornerstone of genetic research and testing.

Market Drivers

The increasing adoption of PCR in clinical diagnostics, particularly for detecting infectious diseases and genetic disorders, is a primary growth driver. Its role in drug development, including biomarker identification and personalized medicine, further fuels demand. Technological advancements, such as improved reagent specificity and automation of PCR systems, enhance efficiency and accuracy, boosting market growth. The rising prevalence of chronic diseases, including cancer and metabolic disorders, also drives demand for advanced diagnostic tools like PCR, supporting market expansion.

Market Restraints

The high cost of PCR instruments and associated consumables poses a significant challenge, particularly for smaller laboratories and facilities in developing regions. This cost barrier may limit adoption and restrain market growth despite the technology's widespread utility.

Market Segmentation

The PCR market is segmented by product type, end-user, and geography. By product type, it includes reagents, instruments, consumables, and software, with reagents expected to hold a significant share due to their high consumption and the variety of tests requiring specialized reagents. Innovations in reagent specificity are further driving this segment's growth. By end-user, the market covers pharmaceuticals and biopharmaceutical companies, diagnostic laboratories, and research institutes. The pharmaceutical and biotechnology sector is anticipated to see steady growth, fueled by ongoing advancements in drug development and personalized medicine. Geographically, the market spans North America, South America, Europe, the Middle East and Africa, and Asia-Pacific. North America is expected to maintain a strong market position due to its advanced healthcare infrastructure and high incidence of chronic diseases requiring sophisticated diagnostics. Asia-Pacific is projected to experience the fastest growth, driven by improved healthcare systems, increased investments in life sciences, and rising research activities.

Key Players

While specific companies are not named, major players in the PCR market are likely focusing on innovation, such as developing high-specificity reagents and automated PCR systems, to strengthen their market positions. Strategic partnerships and investments in research and development are key to addressing evolving diagnostic and research needs.

Market Insights

The market analysis highlights trends in demand, supply, and technological advancements, supported by comprehensive segmentation and regional forecasts. The growing emphasis on precision medicine and early disease detection underscores PCR's importance, particularly in North America and Asia-Pacific. Despite cost-related challenges, the market is set to grow as healthcare investments and technological innovations continue to drive adoption.

In conclusion, the PCR market is positioned for robust growth, propelled by its critical applications in diagnostics and drug development, advancements in reagent technology, and regional healthcare improvements. North America and Asia-Pacific are key growth regions, though high costs may temper expansion. Industry leaders are leveraging innovation to meet rising demand, ensuring PCR remains integral to modern medical and research advancements.

Key Benefits of this Report:

Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

Historical data from 2022 to 2024 & forecast data from 2025 to 2030
Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
Competitive Positioning, Strategies, and Market Share Analysis
Revenue Growth and Forecast Assessment of segments and regions including countries
Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.

Segmentation

By Product Type

Reagents
Instruments
Consumables
Software & Services

By Technology

Conventional PCR
Real-Time PCR
Digital PCR
Others

By Application

Clinical Diagnosis
Forensic Laboratories
Life Science Research
Environmental Testing
Food Safety and Agricultural Testing

By Geography

North America
United States
Canada
Mexico
South America
Brazil
Argentina
Others
Europe
United Kingdom
Germany
France
Italy
Others
Middle East & Africa
Saudi Arabia
UAE
Others
Asia Pacific
Japan
China
India
South Korea
Taiwan
Others

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

2.1. Market Overview
2.2. Market Definition
2.3. Scope of the Study
2.4. Market Segmentation

3. BUSINESS LANDSCAPE

3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Porter's Five Forces Analysis
3.5. Industry Value Chain Analysis
3.6. Policies and Regulations
3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. POLYMERASE CHAIN REACTION (PCR) MARKET BY PRODUCT TYPE

5.1. Introduction
5.2. Reagents
5.3. Instruments
5.4. Consumables
5.5. Software & Services

6. POLYMERASE CHAIN REACTION (PCR) MARKET TECHNOLOGY

6.1. Introduction
6.2. Conventional PCR
6.3. Real-Time PCR
6.4. Digital PCR
6.5. Others

7. POLYMERASE CHAIN REACTION (PCR) MARKET BY APPLICATION

7.1. Introduction
7.2. Clinical Diagnosis
7.3. Forensic Laboratories
7.4. Life Science Research
7.5. Environmental Testing
7.6. Food Safety and Agricultural Testing

8. POLYMERASE CHAIN REACTION (PCR) MARKET BY GEOGRAPHY

8.1. Introduction
8.2. North America
- 8.2.1. By Product Type
- 8.2.2. By Technology
- 8.2.3. By Application
- 8.2.4. By Country
  - 8.2.4.1. United States
  - 8.2.4.2. Canada
  - 8.2.4.3. Mexico
8.3. South America
- 8.3.1. By Product Type
- 8.3.2. By Technology
- 8.3.3. By Application
- 8.3.4. By Country
  - 8.3.4.1. Brazil
  - 8.3.4.2. Argentina
  - 8.3.4.3. Others
8.4. Europe
- 8.4.1. By Product Type
- 8.4.2. By Technology
- 8.4.3. By Application
- 8.4.4. By Country
  - 8.4.4.1. United Kingdom
  - 8.4.4.2. Germany
  - 8.4.4.3. France
  - 8.4.4.4. Italy
  - 8.4.4.5. Others
8.5. Middle East & Africa
- 8.5.1. By Product Type
- 8.5.2. By Technology
- 8.5.3. By Application
- 8.5.4. By Country
  - 8.5.4.1. Saudi Arabia
  - 8.5.4.2. UAE
  - 8.5.4.3. Others
8.6. Asia Pacific
- 8.6.1. By Product Type
- 8.6.2. By Technology
- 8.6.3. By Application
- 8.6.4. By Country
  - 8.6.4.1. Japan
  - 8.6.4.2. China
  - 8.6.4.3. India
  - 8.6.4.4. South Korea
  - 8.6.4.5. Taiwan
  - 8.6.4.6. Others